Menu

• Ask a Health Expert about TYPE III IMMUNE COMPLEX MEDIATED REACTION
• Post Your Side Effect related to TYPE III IMMUNE COMPLEX MEDIATED REACTION
• TYPE III IMMUNE COMPLEX MEDIATED REACTION and FDA Warnings
• TYPE III IMMUNE COMPLEX MEDIATED REACTION in Patients Wiki
• Report TYPE III IMMUNE COMPLEX MEDIATED REACTION in Drug Side Effect Survey

TYPE III IMMUNE COMPLEX MEDIATED REACTION side effect

What is TYPE III IMMUNE COMPLEX MEDIATED REACTION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Temsirolimus Side Effects Report #5473395-8
Pharmacist from CANADA reported TEMSIROLIMUS problem on Sept 26, 2007. Male patient, weighting 167.6 lb, was diagnosed with renal cancer metastatic and was treated with TEMSIROLIMUS. After drug was administered, patient experienced the following problems/side effects: type iii immune complex mediated reaction, . TEMSIROLIMUS dosage: unknown. Patient recovered.

Temsirolimus Side Effects Report #5482653-2
TEMSIROLIMUS problem was reported by a Pharmacist from CANADA on Oct 05, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with TEMSIROLIMUS. After drug was administered, patient experienced the following problems/side effects: type iii immune complex mediated reaction, . TEMSIROLIMUS dosage: unknown. Patient recovered.

Temsirolimus Side Effects Report #5483940-4
Pharmacist from CANADA reported TEMSIROLIMUS problem on Oct 05, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with TEMSIROLIMUS. After drug was administered, patient experienced the following problems/side effects: type iii immune complex mediated reaction, . TEMSIROLIMUS dosage: unknown. Patient recovered.

Natalizumab Side Effects Report #5578476-6
NATALIZUMAB problem was reported by a Physician from GERMANY on Sept 18, 2007. Female patient, 38 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: epilepsy, type iii immune complex mediated reaction, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with GABAPENTIN, PRIMIDONE. Patient was hospitalized. Patient recovered.


Myozyme Side Effects Report #5313709-2
Physician from TAIWAN, PROVINCE OF CHINA reported MYOZYME problem on Apr 11, 2007. Male patient, child 4 years of age, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: pneumonia, skin lesion, type iii immune complex mediated reaction, . MYOZYME dosage: 10 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5269403-X
REMICADE problem was reported by a Health Professional from DENMARK on Mar 08, 2007. Male patient, 53 years of age, was diagnosed with psoriatic arthropathy and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: arthralgia, pyrexia, type iii immune complex mediated reaction, . REMICADE dosage: unknown. During the same period patient was treated with SULFASALAZINE. Patient was hospitalized. Patient recovered.